CSPC Pharmaceutical Group Limited
CSPCY | OTC
$4.07
+$0.13 (+3.30%)
Nov 2, 2026, 11:13 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 7.4B | 3.86B | 3.86B | 4.33B | 10.41B | 10.35B | 4.47B | 5.09B | 6.13B | 5.6B | 5.8B |
Depreciation & Amortization | 707.6M | 1.4B | 1.4B | 1.34B | 1.26B | 1.16B | 1.09B | 1.14B | 1.02B | 864.45M | 831.43M |
Stock-Based Compensation | 115.23M | -72.05M | 20.11M | 210.34M | 256.31M | 256.43M | 178.74M | 144.61M | 86.3M | 7.36M | 5.23M |
Other Working Capital | n/a | n/a | -893.85M | -893.85M | -1.11B | -1.11B | 786.64M | 786.64M | -59.94M | -59.94M | 894.2M |
Other Non-Cash Items | 5.56B | 817.62M | 1.44B | -814.21M | -3.8B | -3.6B | -1.83B | 522.42M | 1.01B | 11.84M | -525.69M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | -193.4M | -193.4M | -3.66B | -3.66B | 786.64M | 786.64M | -1.62B | -1.62B | 1.05B |
Operating Cash Flow | 13.78B | 6.01B | 6.52B | 4.87B | 4.47B | 4.39B | 4.58B | 7.69B | 6.62B | 4.86B | 7.15B |
Capital Expenditures | -1.57B | -1.95B | -2.7B | -2.17B | -1.43B | -1.86B | -2.41B | -2.18B | -1.93B | -1.75B | -1.2B |
Cash Acquisitions | -22.71M | -89.79M | -220.46M | -139.3M | -1.78M | 442.6M | 426.33M | -278.15M | -184.2M | 237.07M | 456.33M |
Purchase of Investments | -3.66B | -5.37B | -3.98B | -4.65B | -2.78B | -4.56B | -5.68B | -7.22B | -7.27B | -5.41B | -8.09B |
Sales Maturities Of Investments | 2.56B | 3.22B | 2.92B | 3.02B | 1.4B | 6.79B | 8.63B | 3.34B | 4.37B | 6.01B | 5.49B |
Other Investing Acitivies | -6.66B | -1.01B | -951.47M | 39.81M | 287.59M | 130.46M | -211.39M | 10.8M | 36.61M | 12.3M | -24.93M |
Investing Cash Flow | -8.65B | -4.2B | -4.31B | -4.39B | -2.64B | 840.9M | 471.13M | -6.76B | -5.14B | -903.24M | -3.38B |
Debt Repayment | 273.1M | -235.49M | -23.98M | -57.59M | -107.93M | 14.16M | -344.35M | -20.27M | 359.41M | -162.63M | -155.98M |
Common Stock Repurchased | -423.61M | -415.91M | -1.71B | -1.81B | -623.29M | -443.73M | -198.85M | -15.58M | -276.9M | -260.25M | n/a |
Dividend Paid | -2.46B | -2.46B | -1.74B | -3.27B | -3.12B | -2.84B | -2.24B | -2.04B | -1.84B | -1.69B | -2.37B |
Other Financial Acitivies | 376.31M | 616.27M | 403.55M | -38.77M | 287.75M | 504.2M | 240.07M | 211.08M | -145.46M | -76.05M | -88.69M |
Financial Cash Flow | -2.21B | -2.47B | -2.97B | -5.09B | -3.62B | -2.83B | -2.55B | -1.86B | -1.91B | -2.19B | -2.61B |
Net Cash Flow | 2.82B | -399.96M | -712.38M | -4.89B | -2.14B | 8.9M | 571.66M | 198.6M | 714.14M | 2.23B | 2.62B |
Free Cash Flow | 12.21B | 4.06B | 3.82B | 2.54B | 2.87B | 2.53B | 2.16B | 5.5B | 4.69B | 3.11B | 5.95B |
Adj. Free Cash Flow | 12.1B | 4.13B | 3.8B | 2.32B | 2.62B | 2.28B | 1.98B | 5.36B | 4.61B | 3.1B | 5.95B |
Maintenance CapEx | -3.47B | -4.12B | -4.13B | -3.74B | -3.07B | -2.42B | -1.89B | -1.28B | -434.41M | -434.41M | -706.46M |
Growth CapEx | -805.23M | n/a | n/a | -280.68M | -778.13M | -1.62B | -2.45B | -2.65B | -2.7B | -2.91B | -2.29B |
Owner Earnings | 16.84B | 6.59B | 6.69B | 5.35B | 5.81B | 9.65B | 9.3B | 11.27B | 13.34B | 11.19B | 11.05B |
Add to Watchlist
Select watchlists to add or remove CSPCY